Reconstitution of microtubule into GTP-responsive nanocapsules

Nat Commun. 2022 Sep 15;13(1):5424. doi: 10.1038/s41467-022-33156-5.

Abstract

Nanocapsules that collapse in response to guanosine triphosphate (GTP) have the potential as drug carriers for efficiently curing diseases caused by cancer and RNA viruses because GTP is present at high levels in such diseased cells and tissues. However, known GTP-responsive carriers also respond to adenosine triphosphate (ATP), which is abundant in normal cells as well. Here, we report the elaborate reconstitution of microtubule into a nanocapsule that selectively responds to GTP. When the tubulin monomer from microtubule is incubated at 37 °C with a mixture of GTP (17 mol%) and nonhydrolysable GTP* (83 mol%), a tubulin nanosheet forms. Upon addition of photoreactive molecular glue to the resulting dispersion, the nanosheet is transformed into a nanocapsule. Cell death results when a doxorubicin-containing nanocapsule, after photochemically crosslinked for properly stabilizing its shell, is taken up into cancer cells that overexpress GTP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Doxorubicin / metabolism
  • Doxorubicin / pharmacology
  • Guanosine Triphosphate / metabolism
  • Microtubules / metabolism
  • Nanocapsules*
  • Tubulin* / metabolism

Substances

  • Nanocapsules
  • Tubulin
  • Doxorubicin
  • Guanosine Triphosphate
  • Adenosine Triphosphate